Page 114 - Human Use News Today

AstraZenecas Beyfortus recommended for approval in the EU by CHMP

− If Approved, Maribavir Would be the First and Only Inhibitor of CMV-specific UL97 Protein Kinase in the EU for Treatment of Adults with Post-transplant CMV Refractory to Prior... | September 16, 2022

LONDON (dpa-AFX) - British drug major AstraZeneca plc (AZN.L, AZN) announced Friday that its Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination, has been

Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union

BRUSSELS (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended the approval

Investegate announcements from AstraZeneca PLC, Nirsevimab recommended for approval in EU by CHMP

FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) announced Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion

Kite’s CAR T-cell Therapy Yescarta® First in Europe to Receive Positive CHMP Opinion for Use in Second-line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

(RTTNews) - Agios Pharmaceuticals, Inc. (AGIO) announced Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Med...

The CHMP had adopted a positive opinion for Beyfortus to treat RSV lower respiratory tract disease in newborns and infants.